DRKS00016029已完成不适用
Evaluation of serum-biomarkers as a surrogate marker for florid MS lesions (contrast enhancement) in patients with multiple sclerosis. - REDUCE-GAD
Klinikum der Johann Wolfgang Goethe-Universität Zentrum der Neurologie und Neurochirurgie0 个研究点目标入组 102 人开始时间: 2019年1月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Planned implementation of a contrast enhanced cerebral or spinal MRI in patients with multiple sclerosis (including clinically isolated syndrome and radiologically isolated syndrome)
排除标准
- •Age of patient < 18 years, other current present neurological diseases such as stroke, dementia, M. Parkinson or similar.
研究者
相似试验
尚未招募
不适用
Markers in abdominal traumaCTRI/2021/04/032510Department of general surgery IMS BH
招募中
不适用
Clinical study for evaluating serum/plasma biomarker levels of healthy subjects to compare with these of patients with lung diseases.Healthy subjectsJPRN-UMIN000020502Department of Respiratory Medicine, Kyorin University School of Medicine100
招募中
不适用
Clinical study on serum biomarkers associated with prognosis and pathology of POEMS syndromePOEMS syndromeJPRN-UMIN000044082Department of Neurology, Graduate School of Medicine, Chiba University100
尚未招募
不适用
ongitudinal study of biological surrogate markers in primary progressive Multiple Sclersosis.10012303MSNL-OMON31170Vrije Universiteit Medisch Centrum20
已完成
3 期
Exploratory analysis of serum and urine biomarkers associated with nausea and vomittings induced by highly emetogenic chemotherapy (Biomarker study of TRIPLE)Thoracic tumorJPRN-UMIN000006143Division of thoracic oncology, Shizuoka Cancer Center80